The AI-powered diagnostic imaging market is on a significant growth trajectory, projected to reach USD 22.58 billion by 2032, expanding at a compound annual growth rate (CAGR) of 26.40% from 2026 to 2032.
This expansion is fueled by a surge in demand for AI-assisted disease detection, advancements in imaging technologies, and increased investments in precision diagnostics. The integration of machine learning and computer vision into radiology is enhancing diagnostic accuracy and addressing the shortage of radiologists, especially in regions with high chronic disease prevalence.
North America currently dominates the market, accounting for about 41% of the share in 2025, thanks to its advanced healthcare infrastructure and favorable regulatory environment. In contrast, the Asia Pacific region is anticipated to grow the fastest, driven by healthcare digitization and government initiatives supporting AI in healthcare.
Key trends include the adoption of cloud-based AI solutions and deep learning technologies, which streamline clinical workflows and improve diagnostic capabilities. As regulatory approvals for AI-based imaging software increase, the market is expected to see further innovations and collaborations between technology developers and healthcare providers, paving the way for enhanced clinical outcomes and operational efficiencies.